AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.2640
+0.0104 (4.10%)
At close: Aug 3, 2026, 4:00 PM EDT
0.2626
-0.0014 (-0.53%)
Pre-market: Aug 4, 2026, 4:14 AM EDT
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $5.83 million as of August 3, 2026. Its market cap has decreased by -25.47% in one year.
Market Cap
5.83M
Enterprise Value
4.52M
1-Year Change
-25.47%
Ranking
Category
Stock Price
$0.26
ChartMarket Cap Chart
Since July 12, 1996, AIM ImmunoTech's market cap has decreased from $40.85M to $5.83M, a decrease of -85.73%. That is a compound annual growth rate of -6.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 5.83M | 80.83% |
| Dec 31, 2025 | 3.22M | -74.47% |
| Dec 31, 2024 | 12.63M | -41.22% |
| Dec 29, 2023 | 21.49M | 43.27% |
| Dec 30, 2022 | 15.00M | -65.93% |
| Dec 31, 2021 | 44.02M | -39.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 5.91M |
| Curanex Pharmaceuticals | 5.82M |
| Xenetic Biosciences | 5.81M |
| Enveric Biosciences | 5.78M |
| Cadrenal Therapeutics | 5.77M |
| Soligenix | 5.54M |
| NuCana | 5.49M |
| BioAtla | 5.46M |